GSK recalls popular heartburn drug Zantac globally after cancer scare

GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution”, days after the U.S. Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug.

Newsletter Signup

Want to recieve regular updates from us, sign up to our newsletter to be in the know.